Utomilumab Uses, Dosage, Side Effects and more
Utomilumab is under investigation in clinical trial NCT03318900 (T Cell Immunotherapy for Advanced Ovarian Cancer).
| Trade Name | Utomilumab |
| Generic | Utomilumab |
| Utomilumab Other Names | PF-05082566, Utomilumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
